← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $434K of Moderna, Inc.

Sold$433,879
$46.84Price
9,263Shares

What MRNA did after the filing

Filed May 22Copier in May 26
The stock from Tue, May 26 open, $47.21
+62.2%
S&P 500, same days
+0.2%

Measured over 30 trading days, to the Jul 9 close.

Traded Thu, May 21. Filed Fri, May 22, 7:00 PM ET, after the close. Returns use the May 26 open and the Jul 9 close. Not investment advice.